EVENITY® Risk Minimisation Materials Effectiveness Measurement in Australia (20220120)

First published 13/04/2023

Last updated 13/05/2024

EU PAS number:

EUPAS104308

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

Protocol-Published Original romosozumab 20220120 (1).pdf

English (353.09 KB - PDF)View document

Study results

Study report

Study report

20220120_ORSR_Abstract_Redacted.pdf

English (1.78 MB - PDF)View document

Other information